Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-001103

CEO and CFO bought 3,400 shares at $12.95 ($44,030)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2025-01-03 Purchase +3,400 $12.95 $44,030 5,547,102 D: show line 1 in the form
Open-market purchases · 3,400 sh · avg $12.95 · $44,030
Loading xslF345X05/ownership.xml…